Hormone Testing Accuracy: Blood vs Saliva vs Urine Compared

Hormone testing accuracy is one of the most searched topics in women's health — roughly 5,000 monthly U.S. searches — because patients are increasingly offered at-home kits, telehealth panels, and "comprehensive" dried-urine reports alongside the traditional blood draw. The methods do not measure the same thing. Serum captures total circulating hormone, saliva captures free (unbound) fraction, and dried urine captures cumulative metabolites. Each has a use case, an evidence base, and a list of clinical caveats. This guide compares the three primary modalities, summarizes what major societies recommend, and outlines how telehealth providers typically order and interpret results.

Key facts at a glance

• Serum (blood) testing is the validated clinical reference standard cited by the Endocrine Society, NAMS, and ACOG.
• Saliva testing measures the free hormone fraction but shows high intra-individual variability and is not recommended for HRT titration by NAMS.
• DUTCH dried-urine panels offer metabolite breakdowns that serum cannot, but are FDA-classified as laboratory-developed tests, not approved diagnostics.
• Cycle timing, assay method (immunoassay vs mass spectrometry), and sample handling each materially affect results.

Which hormone test is most accurate?

For nearly all clinical decisions involving reproductive, adrenal, or thyroid hormones, serum testing analyzed by liquid chromatography-mass spectrometry (LC-MS/MS) is the most accurate available method. A 2010 review in the Journal of Steroid Biochemistry and Molecular Biology documented that LC-MS/MS serum assays achieve coefficients of variation under 10% for estradiol, testosterone, and cortisol, while older immunoassays and saliva-based methods often exceeded 20-25%¹. The Endocrine Society's 2015 clinical practice guideline on menopause specifically calls out serum estradiol and FSH as the recommended diagnostic measurements when laboratory confirmation is needed³.

That said, "most accurate" depends on the question being asked. Serum captures the total hormone pool — including the ~98% bound to sex hormone-binding globulin (SHBG) and albumin. If a clinician needs to assess only the biologically active free fraction, calculated free testosterone (from total testosterone and SHBG) or equilibrium dialysis is more useful than a raw total number. Saliva captures the free fraction directly, but with poor reproducibility. Urine metabolite testing reports a 24-hour average rather than a single point-in-time snapshot.

In short: hormone testing accuracy is not a single ranking. It is the match between the analyte, the question, and the method.

How each method actually works

Serum (blood) testing

A venous blood draw is processed at a CLIA-certified lab using either immunoassay (faster, cheaper, less specific at low concentrations) or LC-MS/MS (gold standard, more expensive, better at distinguishing structurally similar steroids). Common panels include FSH, LH, estradiol, progesterone, total and free testosterone, SHBG, DHEA-S, prolactin, TSH, free T4, and AMH. Reference ranges are well-established and reproducible across major labs (Quest, LabCorp, Mayo) within a few percentage points¹.

Serum is the standard for ovarian reserve assessment (AMH, antral follicle count, day 2-5 FSH), thyroid evaluation, hyperandrogenism workups (PCOS), and pituitary screening. The 2020 ASRM committee opinion on ovarian reserve testing recommends serum AMH and antral follicle count as the most reliable markers⁸.

Saliva testing

Saliva passively diffuses small, non-protein-bound hormone molecules. The result reflects the free fraction. A 2006 Clinical Biochemistry Reviews overview noted that while saliva is convenient for diurnal cortisol curves and some research applications, its accuracy for reproductive hormones is limited by collection technique, contamination from gingival blood, and time-of-day variability⁴. Studies of salivary progesterone have shown intra-day coefficients of variation of 20-30% versus under 10% for serum⁴.

Salivary cortisol — specifically late-night salivary cortisol for Cushing screening — is the one well-validated clinical use case, endorsed in Endocrine Society guidelines. For estradiol, progesterone, and testosterone in menopause management, NAMS does not recommend salivary testing as a basis for dose decisions².

Dried urine (DUTCH and similar)

The DUTCH test (Dried Urine Test for Comprehensive Hormones) collects four small filter-paper samples over 24 hours and analyzes them by mass spectrometry for parent hormones and downstream metabolites — including 2-OH-estrone, 4-OH-estrone, 16-OH-estrone, and various cortisol metabolites⁶. The output is rich: it can show estrogen metabolism pathways and adrenal patterns that serum cannot.

However, the FDA classifies DUTCH as a laboratory-developed test (LDT), meaning it has not undergone FDA premarket review for accuracy or clinical validity⁷. NAMS does not endorse DUTCH for menopausal hormone therapy dose titration², and there is no consensus reference range tied to specific therapeutic outcomes. Many integrative and functional medicine practitioners use it; most board-certified endocrinologists and OB/GYNs do not.

Treatment and clinical decision context

A common patient assumption is that hormone testing tells someone whether they "need" HRT or specific supplementation. Current society guidelines say the opposite. The 2022 NAMS Position Statement is explicit: menopausal hormone therapy decisions are driven by symptom burden, age, time since menopause onset, and individual risk profile — not by a single estradiol value². The Endocrine Society's 2015 guideline reaches the same conclusion³.

Where hormone testing accuracy matters most clinically:

• Confirming menopause in younger women (under 45) with cycle disruption — serum FSH and estradiol can support a premature ovarian insufficiency diagnosis³.
• PCOS workup — total and free testosterone, DHEA-S, SHBG, and 17-hydroxyprogesterone to rule out CAH.
• Ovarian reserve assessment — day 2-5 FSH, AMH, antral follicle count⁸.
• Hyperandrogenism evaluation — serum testosterone, ideally LC-MS/MS rather than immunoassay, especially at low female ranges.
• Thyroid screening — TSH, free T4, with TPO antibodies if Hashimoto's is suspected.

Routine menopause diagnosis in symptomatic women over 45 does not require any hormone test. That is a clinical diagnosis. Discuss timing and panel composition with a clinician familiar with your history.

Telehealth provider options for hormone testing

Several telehealth platforms order hormone panels as part of a clinical intake. The exact panel composition, lab partner, and out-of-pocket cost vary by service.

Midi Health is a NAMS-credentialed virtual menopause clinic that accepts most commercial insurance plans; when bloodwork is ordered, it routes through Quest or LabCorp under standard insurance billing. Winona is a cash-pay, async-first menopause platform that includes optional lab orders as part of its subscription, typically billed separately. Allara focuses on PCOS and hormonal conditions and includes comprehensive metabolic and reproductive hormone panels as part of its multidisciplinary program. Hone Health offers at-home blood-spot kits for testosterone, estradiol, and thyroid markers, with results reviewed by their clinician network.

None of these providers position themselves around DUTCH or salivary panels as primary diagnostics — they default to serum because that is what major society guidelines reference. Patients specifically seeking dried-urine metabolite testing typically work with integrative or functional medicine practitioners outside the major telehealth menopause platforms.

Safety, limitations, and when results can mislead

Hormone test results can produce false reassurance or false alarm in several common scenarios. Patients should be aware:

• Hormonal contraception alters baseline values. Oral contraceptives suppress endogenous FSH, LH, and estradiol and elevate SHBG, which can make free testosterone calculations look artificially low. Cycle-day FSH testing on combined oral contraceptives is not interpretable.
• Biotin supplementation interferes with many immunoassays, particularly thyroid and reproductive hormones, producing falsely high or low results depending on the assay. The FDA issued a safety communication on this in 2017 and recommends stopping biotin 48-72 hours before testing.
• Time of day matters. Testosterone peaks in the morning; cortisol follows a diurnal curve. A 4 PM testosterone draw may read 20-30% lower than an 8 AM draw in the same person.
• Single-point testing in perimenopause is often misleading. FSH and estradiol fluctuate dramatically cycle-to-cycle. A "normal" reading does not rule out perimenopause; a "menopausal" reading does not confirm permanent loss of ovarian function.

Red-flag results that warrant prompt clinician follow-up include markedly elevated prolactin (over 100 ng/mL suggests possible pituitary adenoma), persistently elevated testosterone above the female reference range, TSH outside the laboratory reference range, or any unexpected pattern in a symptomatic patient. Discuss interpretation with a clinician — at-home kits without clinician review are not a substitute for diagnostic evaluation.

Cost and insurance considerations

Out-of-pocket pricing varies widely by method and panel breadth. A basic serum menopause panel (FSH, estradiol, TSH) typically runs $50-$120 if billed self-pay through Quest or LabCorp, and is generally covered by commercial insurance when ordered with an appropriate diagnosis code. Comprehensive panels including AMH, free testosterone with SHBG, DHEA-S, and prolactin run roughly $150-$300 self-pay.

Saliva panels through direct-to-consumer providers typically range from $80-$250 depending on number of analytes; these are almost never covered by commercial insurance. DUTCH Complete and DUTCH Plus panels range from approximately $300-$500 retail, with no standard insurance reimbursement⁷.

At-home blood-spot kits offered by direct-to-consumer testosterone and menopause platforms typically run $100-$200 per panel. These use validated finger-stick capillary collection and LC-MS/MS analysis at a CLIA-certified lab — methodologically closer to serum than to saliva. Insurance reimbursement is uncommon because the order originates outside the traditional clinician-laboratory pathway.

Discuss with a clinician which test, which lab, and which billing pathway makes sense for your specific question before ordering.

Frequently asked questions

How accurate is saliva hormone testing compared to blood? Saliva testing measures free hormone fractions and can show clinically meaningful variability — published studies report intra-day coefficients of variation of 20-30% or higher, while validated serum assays typically run under 10%. Hormone testing accuracy is highest for serum estradiol, FSH, testosterone, and TSH using mass spectrometry.

Is DUTCH testing FDA-approved? No. DUTCH (Dried Urine Test for Comprehensive Hormones) is a laboratory-developed test offered under CLIA regulations. The FDA does not clear or approve it as a diagnostic device, and NAMS does not recommend it for guiding menopausal hormone therapy decisions.

What hormones should be tested for perimenopause? Routine perimenopause diagnosis does not require hormone testing — it is a clinical diagnosis based on cycle changes and symptoms. When testing is indicated, common serum panels include FSH, estradiol, TSH, and sometimes prolactin or AMH. A clinician interprets results within cycle context.

Does insurance cover hormone testing? Most commercial plans cover medically indicated serum hormone panels (FSH, estradiol, TSH, testosterone) when ordered by a clinician with an appropriate diagnosis code. Saliva and dried-urine panels are typically considered investigational and are paid out-of-pocket, often $200-$500.

Can hormone testing tell me if I need HRT? Hormone testing alone does not determine HRT candidacy. NAMS guidelines emphasize that menopausal hormone therapy decisions are based on symptoms, age, time since menopause, and individual risk factors — not on absolute hormone levels. Results inform but do not dictate treatment.

When is the best time in the cycle to test hormones? Timing depends on the analyte. Estradiol and progesterone vary across the cycle; progesterone is typically drawn day 21 of a 28-day cycle to confirm ovulation. FSH and AMH can be drawn day 2-5 for ovarian reserve assessment. Postmenopausal patients can be tested any day.

Sources

1. Stanczyk FZ, Clarke NJ. Advantages and challenges of mass spectrometry assays for steroid hormones. J Steroid Biochem Mol Biol. 2010;121(3-5):491-495. https://pubmed.ncbi.nlm.nih.gov/20470886/
2. The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. https://pubmed.ncbi.nlm.nih.gov/35797481/
3. Stuenkel CA, Davis SR, Gompel A, et al. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. https://pubmed.ncbi.nlm.nih.gov/26444994/
4. Lewis JG. Steroid analysis in saliva: an overview. Clin Biochem Rev. 2006;27(3):139-146. https://pubmed.ncbi.nlm.nih.gov/17268583/
5. ACOG Committee Opinion No. 532: Compounded bioidentical menopausal hormone therapy. Obstet Gynecol. 2012;120(2 Pt 1):411-415 (reaffirmed 2020). https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2012/08/compounded-bioidentical-menopausal-hormone-therapy
6. Newman M, Pratt SM, Curran DA, Stanczyk FZ. Evaluating urinary estrogen and progesterone metabolites using dried filter paper samples and gas chromatography with tandem mass spectrometry. BMC Chem. 2019;13(1):20. https://pubmed.ncbi.nlm.nih.gov/31384765/
7. U.S. Food and Drug Administration. Laboratory Developed Tests. https://www.fda.gov/medical-devices/in-vitro-diagnostics/laboratory-developed-tests
8. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020;114(6):1151-1157. https://pubmed.ncbi.nlm.nih.gov/33280722/

Related brands & guides

• Midi Health review — NAMS-credentialed virtual menopause care, accepts insurance
• Winona review — cash-pay async menopause platform with optional lab panels
• Allara review — multidisciplinary PCOS and hormonal-condition care with comprehensive labs
• Hone Health review — at-home blood-spot hormone testing with clinician review

Some brand mentions link to our editorial reviews. Updated May 29, 2026. Reviewed by Dr. Maya Chen, MD, NAMS-CMP.